Cybin Inc. Files 6-K with Patent News
Ticker: HELP · Form: 6-K · Filed: Oct 24, 2024 · CIK: 1833141
| Field | Detail |
|---|---|
| Company | Cybin INC. (HELP) |
| Form Type | 6-K |
| Filed Date | Oct 24, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, patent, news-release
TL;DR
Cybin Inc. dropped patent news on 10/24, check the 6-K.
AI Summary
On October 24, 2024, Cybin Inc. filed a Form 6-K, reporting a news release dated October 24, 2024. This filing includes Exhibit 99.1, which is a patent press release from Cybin. The company is incorporated in Ontario and its principal executive offices are located at 100 King Street West, Suite 5600, Toronto, Ontario, M5X 1C9.
Why It Matters
This filing indicates Cybin Inc. is actively pursuing intellectual property protection for its innovations, which is crucial for a pharmaceutical company in the development phase.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Cybin Inc. faces inherent risks related to drug development, regulatory approvals, and market adoption, which are amplified by the speculative nature of its industry.
Key Players & Entities
- Cybin Inc. (company) — Registrant
- Doug Drysdale (person) — Chief Executive Officer
- October 24, 2024 (date) — Filing and News Release Date
- 100 King Street West, Suite 5600, Toronto, Ontario, M5X 1C9 (location) — Principal Executive Offices
FAQ
What is the primary purpose of this Form 6-K filing?
The Form 6-K filing is to report a news release dated October 24, 2024, which includes Exhibit 99.1, a patent press release from Cybin Inc.
Who signed the Form 6-K on behalf of Cybin Inc.?
Doug Drysdale, Chief Executive Officer, signed the Form 6-K on behalf of Cybin Inc.
What is the filing date of this report?
The filing date of this report is October 24, 2024.
Where are Cybin Inc.'s principal executive offices located?
Cybin Inc.'s principal executive offices are located at 100 King Street West, Suite 5600, Toronto, Ontario, M5X 1C9.
What type of document is included as Exhibit 99.1?
Exhibit 99.1 is a news release dated October 24, 2024, specifically a patent press release from Cybin Inc.
Filing Stats: 147 words · 1 min read · ~1 pages · Grade level 10.6 · Accepted 2024-10-24 15:47:55
Filing Documents
- cybininc-form6xk10x24x2024.htm (6-K) — 11KB
- a10-24x2024cyb005patentprf.htm (EX-99.1) — 17KB
- image_0a.jpg (GRAPHIC) — 25KB
- 0001628280-24-043606.txt ( ) — 63KB
From the Filing
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October, 2024. Commission File Number 001-40673 Cybin Inc. (Exact Name of Registrant as Specified in Charter) 100 King Street West, Suite 5600, Toronto, Ontario, M5X 1C9 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CYBIN INC. (Registrant) Date October 24, 2024 By s Doug Drysdale Name Doug Drysdale Title Chief Executive Officer EXHIBIT INDEX 99.1 News Release dated October 24, 2024